Reviewed by Michael Gill, B. Sc.
25 Kidney Failure Clinical Trials Near Me
Top Hospitals for Kidney Failure Clinical Trials
Image of Clinical Advancement Center, PLLC in Texas.
Clinical Advancement Center, PLLC
San Antonio
7Active Trials
2All Time Trials for Kidney Failure
2014First Kidney Failure Trial
Image of South Florida Research Institute in Florida.
South Florida Research Institute
Lauderdale Lakes
5Active Trials
1All Time Trials for Kidney Failure
2012First Kidney Failure Trial
Top Cities for Kidney Failure Clinical Trials
Kidney Failure Clinical Trials by Phase of Trial
Phase 1 Kidney Failure Clinical Trials
13Active Kidney Failure Clinical Trials
13Number of Unique Treatments
60Number of Active Locations
PF-07321332 (nirmatrelvir)/ritonavir participants with severe renal impairment on hemodialysisUKidneyMK-2060Alkalizing Fruit and VegetablesCLBS201Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single InfusionAutologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower DoseEffCaMgCitrate 480 mg
Kidney Failure Clinical Trials by Age Group
< 18 Kidney Failure Clinical Trials
5Active Kidney Failure Clinical Trials
ParicalcitolFerumoxytolFinerenone (Kerendia, BAY94-8862)Ferric CitrateTolvaptan (OPC-41061)
Top Treatments for Kidney Failure Clinical Trials
Treatment Name
Active Kidney Failure Clinical Trials
All Time Trials for Kidney Failure
First Recorded Kidney Failure Trial
Renal Autologous Cell Therapy (REACT®)
3
3
2016
Finerenone (Kerendia, BAY94-8862)
2
2
2022
MK-2060
2
3
2019
Semaglutide
2
2
2019
InnAVasc arteriovenous graft surgical implant
2
2
2019
Recently Completed Studies with FDA Approved Treatments for Kidney Failure
Treatment
Year
Sponsor
BAY2976217
2020
Bayer
BAY1213790
2020
Bayer
MK-2060
2019
Merck Sharp & Dohme Corp.
glecaprevir/pibrentasvir treatment
2019
Raymond Chung

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: November 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.